Impact of genetics on neoadjuvant therapy with complete pathological response in metastatic colorectal cancer: Case report and review of the literature Cover

.blurhash-client-img { display: none !important; }

Impact of genetics on neoadjuvant therapy with complete pathological response in metastatic colorectal cancer: Case report and review of the literature

Balkan Journal of Medical Genetics

Volume 22 (2019): Issue 1 (June 2019)

By: P Bulajic, N Bidzic, V Djordjevic, Μ Ceranic, D Βasaric, V Pesic and J Djordjevic-Pesic

Open Access

|Aug 2019

Figures & Tables

(a): Preoperative histopathology-adenocarcinoma; (b), (c), (d), (e), (f): preoperative CT of primary and secondary tumors; (g), (h), (i), (j), (k): CT after neoadjuvant therapy; (1), (m): complete pathological response of primary rectal tumor and secondary liver metastases in S3, respectively; (n), (o), (p): CT shows vanishing liver metastases 4 months after the operation.

DOI: https://doi.org/10.2478/bjmg-2019-0004 | Journal eISSN: 2199-5761

Journal RSS Feed

Language: English

Page range: 75 - 80

Published on: Aug 28, 2019

Published by: Macedonian Academy of Sciences and Arts

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

KRAS (Kirsten rat sarcoma) gene mutation,

Metastatic colorectal cancer,

Pathological complete response,

Vanishing metastases

Related subjects:

Basic medical science,

Basic medical science, other

© 2019 P Bulajic, N Bidzic, V Djordjevic, Μ Ceranic, D Βasaric, V Pesic, J Djordjevic-Pesic, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 22 (2019): Issue 1 (June 2019)Next article